Výsledky vyhľadávania - "Stoszek, Sonia K"
-
1
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
ISSN: 0028-4793, 1533-4406, 1533-4406Vydavateľské údaje: United States Massachusetts Medical Society 14.12.2023Vydané v The New England journal of medicine (14.12.2023)“…In a placebo-controlled, phase 2–3 trial, one dose of mRNA-1345 led to a lower incidence of RSV disease among adults 60 years of age or older. Solicited local…”
Získať plný text
Journal Article -
2
Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis
ISSN: 1537-6613, 1537-6613Vydavateľské údaje: United States 07.10.2020Vydané v The Journal of infectious diseases (07.10.2020)“…Respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) constitutes a substantial disease burden in older adults aged ≥65 years. We aimed…”
Zistit podrobnosti o prístupe
Journal Article -
3
Global and Regional Burden of Hospital Admissions for Pneumonia in Older Adults: A Systematic Review and Meta-Analysis
ISSN: 1537-6613, 1537-6613Vydavateľské údaje: United States 07.10.2020Vydané v The Journal of infectious diseases (07.10.2020)“…Pneumonia constitutes a substantial disease burden among adults overall and those who are elderly. We aimed to identify all studies investigating the disease…”
Zistit podrobnosti o prístupe
Journal Article -
4
Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
ISSN: 1549-1676, 1549-1277, 1549-1676Vydavateľské údaje: United States Public Library of Science 01.10.2010Vydané v PLoS medicine (01.10.2010)“…Approximately 800,000 children die each year due to pneumococcal disease and >90% of these deaths occur in developing countries where few children have access…”
Získať plný text
Journal Article -
5
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults
ISSN: 0022-1899, 1537-6613, 1537-6613Vydavateľské údaje: US Oxford University Press 15.11.2024Vydané v The Journal of infectious diseases (15.11.2024)“…Abstract Background The mRNA-1345 vaccine demonstrated efficacy against respiratory syncytial virus (RSV) disease with acceptable safety in adults aged ≥60…”
Získať plný text
Journal Article -
6
Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial
ISSN: 2041-1723, 2041-1723Vydavateľské údaje: London Nature Publishing Group UK 03.07.2025Vydané v Nature communications (03.07.2025)“…Identifying an immunologic marker as a correlate of protection (CoP) for RSV vaccination is important. In the pivotal phase 3 trial, the mRNA-1345 vaccine…”
Získať plný text
Journal Article -
7
Adverse infant outcomes following low-risk pregnancies in England: a retrospective cohort study
ISSN: 1471-2393, 1471-2393Vydavateľské údaje: London BioMed Central 09.05.2023Vydané v BMC pregnancy and childbirth (09.05.2023)“…Background There are limited data describing adverse infant outcomes in infants born to women with a low risk of complications during pregnancy, such as those…”
Získať plný text
Journal Article -
8
Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12–59 months
ISSN: 2164-5515, 2164-554X, 2164-554XVydavateľské údaje: United States Taylor & Francis Group 01.12.2025Vydané v Human vaccines & immunotherapeutics (01.12.2025)“…Respiratory syncytial virus (RSV) is a common respiratory pathogen in children. After demonstrating safety and immunogenicity in adults, mRNA-1345 encoding the…”
Získať plný text
Journal Article -
9
Facilitating safety evaluation in maternal immunization trials: a retrospective cohort study to assess pregnancy outcomes and events of interest in low-risk pregnancies in England
ISSN: 1471-2393, 1471-2393Vydavateľské údaje: London BioMed Central 01.06.2022Vydané v BMC pregnancy and childbirth (01.06.2022)“…Background Maternal characteristics like medical history and health-related risk factors can influence the incidence of pregnancy outcomes and…”
Získať plný text
Journal Article -
10
Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trial
ISSN: 2212-5345, 2212-5353, 2212-5353Vydavateľské údaje: Netherlands Elsevier B.V 01.11.2024Vydané v Respiratory investigation (01.11.2024)“…Respiratory syncytial virus (RSV) represents a global health concern, including in older adults. This study assessed the safety and immunogenicity of…”
Získať plný text
Journal Article -
11
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
ISSN: 2193-8229, 2193-6382Vydavateľské údaje: Cheshire Springer Healthcare 01.01.2025Vydané v Infectious diseases and therapy (01.01.2025)“…Introduction As no standard case definitions for respiratory syncytial virus—associated lower respiratory tract disease (RSV-LRTD) in adults are available ,…”
Získať plný text
Journal Article -
12
Incidence of RSV in Adults: A Comprehensive Review of Observational Studies and Critical Gaps in Information
ISSN: 0022-1899, 1537-6613, 1537-6613Vydavateľské údaje: US Oxford University Press 16.12.2024Vydané v The Journal of infectious diseases (16.12.2024)“…Abstract Background We conducted a global comprehensive literature review of observational studies reporting respiratory syncytial virus (RSV) incidence in…”
Získať plný text
Journal Article -
13
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
ISSN: 0022-1899, 1537-6613, 1537-6613Vydavateľské údaje: US Oxford University Press 23.09.2024Vydané v The Journal of infectious diseases (23.09.2024)“…Abstract Background An mRNA-based respiratory syncytial virus (RSV) vaccine, mRNA-1345, is under clinical investigation to address RSV disease burden in older…”
Získať plný text
Journal Article -
14
Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial
ISSN: 0022-1899, 1537-6613, 1537-6613Vydavateľské údaje: US Oxford University Press 23.09.2024Vydané v The Journal of infectious diseases (23.09.2024)“…Abstract Background Respiratory syncytial virus (RSV) presents a global health concern. A lipid nanoparticle–encapsulated mRNA-based RSV vaccine (mRNA-1345)…”
Získať plný text
Journal Article -
15
Disease Burden Estimates of Respiratory Syncytial Virus related Acute Respiratory Infections in Adults With Comorbidity: A Systematic Review and Meta-Analysis
ISSN: 1537-6613, 1537-6613Vydavateľské údaje: 12.08.2022Vydané v The Journal of infectious diseases (12.08.2022)“…Respiratory syncytial virus related acute respiratory infection (RSV-ARI) constitutes a substantial disease burden in adults with comorbidities. We aimed to…”
Zistit podrobnosti o prístupe
Journal Article -
16
High prevalence of hepatitis E antibodies in pregnant Egyptian women
ISSN: 0035-9203Vydavateľské údaje: England 01.02.2006Vydané v Transactions of the Royal Society of Tropical Medicine and Hygiene (01.02.2006)“…The epidemiology of hepatitis E virus (HEV), an enterically-transmitted cause of acute viral hepatitis (AVH), is not fully understood. During outbreaks on the…”
Zistit podrobnosti o prístupe
Journal Article -
17
Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood
ISSN: 1537-6613, 1537-6613Vydavateľské údaje: United States 07.10.2020Vydané v The Journal of infectious diseases (07.10.2020)“…Recurrent wheeze and asthma in childhood are commons causes of chronic respiratory morbidity globally. We aimed to explore the association between respiratory…”
Zistit podrobnosti o prístupe
Journal Article -
18
Safety, Tolerability, and Immunogenicity of Revaccination with mRNA-1345, an mRNA Vaccine Against RSV, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years
ISSN: 1537-6591, 1537-6591Vydavateľské údaje: United States 23.09.2025Vydané v Clinical infectious diseases (23.09.2025)“…mRNA-1345 is a respiratory syncytial virus (RSV) vaccine approved for prevention of RSV-associated lower respiratory tract disease in individuals ≥60 years…”
Zistit podrobnosti o prístupe
Journal Article -
19
Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings
ISSN: 0022-1899, 1537-6613, 1537-6613Vydavateľské údaje: US Oxford University Press 26.08.2022Vydané v The Journal of infectious diseases (26.08.2022)“…Abstract Background The true burden of lower respiratory tract infections (LRTIs) due to respiratory syncytial virus (RSV) remains unclear. This study aimed to…”
Získať plný text
Journal Article -
20
Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial
ISSN: 1473-3099, 1474-4457, 1474-4457Vydavateľské údaje: United States Elsevier Ltd 01.04.2025Vydané v The Lancet infectious diseases (01.04.2025)“…Coadministration of a respiratory syncytial virus (RSV) vaccine with seasonal influenza or SARS-CoV-2 vaccines could reduce health-care visits and increase…”
Získať plný text
Journal Article